live attenuated vaccine (Valneva SE)

N/A

Report date: 2025/03/20 20:00:06

Base Information

Drug Namelive attenuated vaccine (Valneva SE)

Drug Alias NameN/A

ClassificationVaccines > Development/production technology > Live attenuated vaccineVaccines > Application > Therapeutic vaccineVaccines > Application > Prophylactic vaccine

Mechanisms of ActionImmunomodulators

TargetsNot applicable

Therapy Area/IndicationsYellow Fever

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryFrance

CombinationsNo

Global Highest StatusPending (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesVivalis SA

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesVivalis SA

Active IndicationsN/A

Inactive IndicationsYellow Fever

Other Information

ATC CodeN/A